Key result
FHI research of the contraceptive spermicide nonoxynol-9 (N-9) – once considered a promising microbicidal candidate – reversed decades of incorrect information about the product's effectiveness in protecting against STIs. FHI research to assess this product's effectiveness in preventing male to female transmission of gonorrhea and chlamydia in high-risk women found that N-9 does not protect against these infections. Based in part on these research results, the World Health Organization is revising its recommendations on N-9 use, and has drafted a policy statement highlighting the need for spermicides that are also microbicides.
For more information
See the microbicides topics page.